| Name | Title | Contact Details |
|---|
Ancillary Care Services is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Privis Health is a leading provider of innovative data-driven population health programs and technology rich services that enable healthcare providers to deliver high quality efficient care to their patient population. Our scalable, cloud-based platform empowers healthcare providers to better manage risk, while achieving their operating and performance goals as they transition from fee-for-service to value based reimbursement. In addition, we assist with the design, implementation and expansion of population health programs, while sharing in the accountability for the success of these initiatives. The Privis team has deep experience with a programmatic approach to provide strategies on service models, organizational transformation, quality improvements and learning health system activities. Offerings include care management, care coordination, transitions of care, chronic care management, and complex CCM programs working in tandem with patient engagement and placement services. We provide a tool kit of evidence-based chronic disease and socio-behavioral assessments that drive the creation of a dynamic shared care plan. Our gaps-in-care offering captures important variances in care, such as preventive care, community resources, and guides interventions to assist the patient in achieving better outcomes and appropriate interventions
Lawrence Hospital Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lawrence Hospital Center is based in Bronxville, NY. You can find more information on Lawrence Hospital Center at www.lawrencehealth.org
NeuroSigma is a Los Angeles-based life sciences company established to develop TNS technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD).
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.